Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
159.05
-8.24 (-4.92%)
Streaming Delayed Price
Updated: 1:02 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
3
4
5
6
7
8
9
...
59
60
Next >
Healis Therapeutics' asset CKDB-501A shares Phase III topline results for glabellar injections from CKD Bio in South Korea
February 27, 2024
From
Healis Therapeutics
Via
GlobeNewswire
3 Magnificent Dividend Growth Stocks to Buy Now and Hold for at Least a Decade
February 27, 2024
These stocks don't offer the highest yields, but their payouts are growing fast.
Via
The Motley Fool
Why Is Generic Drugs Player Teva Pharma Stock Trading Higher Today?
February 26, 2024
FDA-approved Simlandi (adalimumab-ryvk): a high-concentration biosimilar to Humira for rheumatoid arthritis, psoriasis, and more.
Via
Benzinga
3 Dividend Stocks That Are No-Brainer Buys Right Now
February 24, 2024
These stocks check off multiple boxes for investors.
Via
The Motley Fool
Is AbbVie Stock a Buy Now?
February 22, 2024
Management pivoting a $300 billion company as quickly as it has is nothing short of remarkable.
Via
The Motley Fool
AbbVie Inc. (NYSE: ABBV) Records 52-Week High Friday Morning
February 16, 2024
Via
Investor Brand Network
AbbVie Stock Clears Key Benchmark, Hitting 80-Plus RS Rating
February 14, 2024
A Relative Strength Rating upgrade for AbbVie shows improving technical performance.
Via
Investor's Business Daily
AbbVie Options Trading: A Deep Dive into Market Sentiment
February 07, 2024
Via
Benzinga
5 Forever Dividend Stocks to Build Your Portfolio
February 20, 2024
These five stocks are high quality and reliable.
Via
The Motley Fool
3 Magnificent Growth Stocks to Buy Right Now
February 19, 2024
These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects.
Via
The Motley Fool
3 Cash Cows to Boost Your Confidence During the February Chill
February 18, 2024
The market can be a tricky place. Bet on these cash cow stocks to help restore confidence and extract steady returns.
Via
InvestorPlace
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
February 15, 2024
EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NYSE:MRK) EQNX::TICKER_END
Via
FinancialNewsMedia
AbbVie Inc. (NYSE: ABBV) Records 52-Week High Wednesday Morning
February 07, 2024
Via
Investor Brand Network
$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
February 06, 2024
Via
Benzinga
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
February 15, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Beyond Nvidia: How To Navigate Investing In Your 40s — Insights From Reddit
February 14, 2024
A Reddit user reached out to the community seeking advice beyond the hunt for the "next NVIDIA Corp." Here's a sample of the responses.
Via
Benzinga
2 Magnificent Dividend Growth Stocks to Load Up On Right Now
February 06, 2024
These two dividend-growth stocks are fantastic buys.
Via
The Motley Fool
AbbVie Analysts Boost Their Forecasts Following Strong Earnings
February 05, 2024
AbbVie Inc (NYSE: ABBV) reported better-than-expected fourth-quarter earnings on Friday.
Via
Benzinga
The 7 Best Momentum Stocks You Can Purchase Today
February 12, 2024
If you’re looking for hot opportunities in the market, here are just a few of the best momentum stocks to buy today.
Via
InvestorPlace
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
February 12, 2024
These incredible businesses have long histories of successes behind them, and more to come.
Via
The Motley Fool
These 17 Words From AbbVie's CEO Explain Why the Stock Is Still a Buy
February 11, 2024
The drugmaker is handling its biggest obstacle yet relatively well.
Via
The Motley Fool
Jim Cramer Looks At Blackstone, Praises MercadoLibre: 'They're Incredibly Smart'
February 09, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Freeport-McMoRan Inc. (NYSE: FCX) could go higher by a "couple of points, once the Chinese start manipulating their market higher, but that’s all...
Via
Benzinga
3 Stocks Just Hit New 52-Week Highs. Should You Still Be Buying?
February 08, 2024
Letting your winners run is a proven way to generate extraordinary portfolio returns without cutting them off by taking profits.
Via
InvestorPlace
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
February 06, 2024
These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry.
Via
InvestorPlace
7 Russell 2000 Stocks to Buy for the Next Bull Run: February 2024
February 06, 2024
Unveil these standout Russell 2000 stocks, meticulously picked to harness the potential of the evolving market landscape in the 2024 surge.
Via
InvestorPlace
UBS Bullish On This Depression Drug Maker, Says Alzheimer's Agitation Data Is Attractive Catalyst
February 06, 2024
UBS bullish on Axsome's Auvelity launch and pipeline, foreseeing $1 billion sales by 2030. Buy rating, $111 price target. Positive Phase 3 data for Alzheimer's Agitation and Narcolepsy.
Via
Benzinga
7 Dividend Stocks Worth Holding for the Long Haul
February 06, 2024
These dividend stocks are worth holding for the long term both for upside and income production that can add up quickly.
Via
InvestorPlace
Why AbbVie Stock Flew Higher on Monday
February 05, 2024
Investors and pundits alike continued to be impressed by the company's latest earnings report.
Via
The Motley Fool
Drug Maker AbbVie Stock Sees RS Rating Jump To 81
February 05, 2024
AbbVie stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 78 to 81.
Via
Investor's Business Daily
Better Dividend Stock: Pfizer vs. AbbVie
February 05, 2024
Both offer above-average yields but which can deliver the most dividend income over the long run?
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
59
60
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.